QIAGEN Inc.
27220 Turnberry Lane
Suite 200
Valencia
California
91355
United States
Tel: 800-426-8157
Fax: 800-718-2056
Website: http://www.qiagen.com/
About QIAGEN Inc.
QIAGEN N.V., a Netherlands holding company, is the leading global provider of sample and assay technologies. Sample technologies are used to isolate and process DNA, RNA and proteins from biological samples such as blood or tissue. Assay technologies are used to make such isolated biomolecules visible. QIAGEN has developed and markets more than 500 sample and assay products as well as automated solutions for such consumables. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN's assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide. This panel includes the digene HPV Test, which is regarded as the "gold standard" in testing for high-risk types of human papillomavirus (HPV), the primary cause of cervical cancer. The company employs more than 3,100 people in over 30 locations worldwide. QIAGEN’s North American headquarters is in Germantown, Maryland and its global headquarters is located in Hilden, Germany.
Further information about QIAGEN can be found at http://www.qiagen.com/.
114 articles about QIAGEN Inc.
-
The Day In Review: Dyax Corp. Jumps On Positive Data
4/13/2007
-
QIAGEN Inc. Release: QIAcube Wins Red Dot Design Award
3/28/2007
-
QIAGEN Inc. to Present at Lehman Brothers 10th Annual Global Healthcare Conference
3/15/2007
-
QIAGEN Inc. Significantly Expands Its Portfolio Of Licenses To Real-Time PCR
2/13/2007
-
QIAGEN Inc. Reports Strong Fourth Quarter And Fiscal Year-End 2006 Results
2/13/2007
-
QIAGEN Inc. Unveils Revolutionary Sample Processing Platform
1/29/2007
-
QIAGEN Inc. Reports Strong Third Quarter 2006 Results
11/14/2006
-
QIAGEN Inc. To Present At The UBS Warburg Global Life Sciences Conference
9/19/2006
-
QIAGEN Inc. Reports Strong First Quarter 2006 Results
5/9/2006
-
QIAGEN Inc. Announces Offering Of Convertible Notes
5/9/2006
-
Germany's QIAGEN Inc. In Deal With Applied Biosciences Corporation
12/5/2005
-
QIAGEN Inc. Reports Third Quarter 2005 Results
11/8/2005
-
QIAGEN N.V. Invites You To Join Its Fourth Quarter And Year End 2004 Earnings Conference Call On The Web
2/8/2005
-
Qiagen NV Pays $28.5M Cash For Molecular Staging Technology
9/29/2004